Implications of the ACCORD, ADVANCE and VA Diabetes Trials

ReachMD Healthcare Image

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Details

Presenters

Comments

Overview
The ACCORD, ADVANCE and VA Diabetes Trials seem to indicate that there is no real benefit of intensive glycemic control on cardiovascular events in patients with type 2 diabetes. Join host Dr. Steven Edelman and his guest, executive director of the International Diabetes Center at Park Nicollet, Dr. Richard Bergenstal, as they discuss the implications on clinical care and benefits of glycemic control.

Richard Bergenstal, MD

Richard Bergenstal, MD

Steven Edelman, MD

Steven Edelman, MD

Recommended

Details

Presenters

Comments

Overview
The ACCORD, ADVANCE and VA Diabetes Trials seem to indicate that there is no real benefit of intensive glycemic control on cardiovascular events in patients with type 2 diabetes. Join host Dr. Steven Edelman and his guest, executive director of the International Diabetes Center at Park Nicollet, Dr. Richard Bergenstal, as they discuss the implications on clinical care and benefits of glycemic control.

Richard Bergenstal, MD

Richard Bergenstal, MD

Steven Edelman, MD

Steven Edelman, MD

Program Chapters

Segment Chapters

Playlist:

Recommended